Provepharm logo — Act to improve life

Provepharm

Act to improve life

Founded 1998 France France 156 employees Private Equity Total: $165.20M Health Care, Life Sciences +1

General Information

Company Name Provepharm
Founded Year 1998
Location France France +1
Employees 156
Industries Health Care, Life Sciences, Pharmaceutical
Funding Stage Private Equity
Social

Get notified when Provepharm moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Provepharm

Provepharm is an international specialty pharmaceutical company committed to improving patients' lives through innovative solutions. Founded in 1998 and headquartered in France, the company focuses on developing, manufacturing, and marketing a range of hospital products including antidotes and dyes. With expertise in the endoscopic and surgical dye markets, Provepharm has a global presence, operating in over 25 countries. The company's dedication to research and development is evident as it allocates 20% to 25% of its revenues to R&D efforts. In September 2021, Provepharm secured a significant €120.00M investment in a Private Equity Round. The investment was led by Bpifrance, Société Générale, Tikehau Capital, BNP Paribas, Crédit Agricole Alpes Provence, and Banque Populaire Méditerranée.

Taxonomy: specialty pharmaceuticals, hospital products, antidotes, dyes, endoscopic dyes, surgical dyes, healthcare services, clinical practices, R&D investment, global market expansion, life sciences research, pharmaceutical manufacturing, molecule vitalization, research services, specialty care

Services & Products

Development and production of pharmaceutical specialties
medical devices
and hospital care solutions

Target Customers

Hospitals healthcare facilities and patients with critical medical needs

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 6
Investor Investor Investor Investor
•••• ••••
08 Sep 2021
Debt Financing •••••• 4
Investor Investor
•••• ••••
09 May 2019
Series A •••••• 3
Investor Investor
•••• ••••
01 Dec 2011

Provepharm Alternatives & Competitors

Provepharm vs
DWK Life Sciences
DWK Life Sciences United States

DWK Life Sciences is a leading global manufacturer and supplier of precision labware and primary pac...

413 employees
Biotechnology, Life Sciences
Provepharm vs

Leading Innovation in Personal Care & Photochromics Since 1840.

32 employees
Manufacturing, Wellness Beauty
Provepharm vs

Chemistry that makes the world smile

16 employees
Manufacturing

FAQ About Provepharm

Act to improve life
Provepharm was founded in 1998.
Provepharm is headquartered in France.
Provepharm operates in the following industries: Health Care, Life Sciences, Pharmaceutical.
Provepharm has approximately 156 employees.
Provepharm has completed 3 funding rounds, raising a total of $165.20M. The latest funding stage is Private Equity.
Provepharm offers: Development and production of pharmaceutical specialties, medical devices, and hospital care solutions.
Top alternatives and competitors to Provepharm include DWK Life Sciences, James Robinson Speciality Ingredients, B R Impex, TARO PHARMACEUTICALS CANADA , GDCI India Private Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Provepharm and DWK Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Provepharm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes